Am J Hematol. 2024 Jun 11. doi: 10.1002/ajh.27380. Online ahead of print.
NO ABSTRACT
PMID:38860647 | DOI:10.1002/ajh.27380
Recent Content
- (no title)
- Efficacy of novel therapies for refractory and relapsed multiple myeloma in China: A scoping systematic review
- Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
- Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
- (no title)
- Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
- Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progression
- (no title)
- (no title)
- Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes